Promimic AB (publ)

Stockholm Stock Exchange PRO.ST

Promimic AB (publ) EBITDA Margin for the year ending December 31, 2023: -9.94%

Promimic AB (publ) EBITDA Margin is -9.94% for the year ending December 31, 2023, a 87.29% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

Promimic AB (publ) EBITDA Margin for the year ending December 31, 2022 was -78.19%, a 54.48% change year over year.
Promimic AB (publ) EBITDA Margin for the year ending December 31, 2021 was -171.76%, a 21.95% change year over year.
Promimic AB (publ) EBITDA Margin for the year ending December 31, 2020 was -220.06%, a -34.10% change year over year.
Promimic AB (publ) EBITDA Margin for the year ending December 31, 2019 was -164.11%, a 49.52% change year over year.

Key data

Date	EBITDA Margin	EBIT Margin	Depreciation and Amortization	EBIT

Stockholm Stock Exchange: PRO.ST

Promimic AB (publ)

CEO	Mr. Magnus Larsson
IPO Date	April 29, 2022
Location	Sweden
Headquarters	AZ BioVentureHub
Employees	17
Sector	Health Care
Industries Biotechnology Chemicals & Advanced Materials Pharmaceuticals

Description

Promimic AB (publ) manufactures, markets, and sells biomaterials for improved osseointegration for orthopedic and dental implants markets. It offers HAnano surface technology that combines various properties that are known to improve osseointegration into one unique surface modification. The company was incorporated in 2004 and is headquartered in Mölndal, Sweden.

Key trends

Past 5 years